![CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.2015.65.6520/asset/images/large/jco656520f2.jpeg)
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology
![Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models | Blood Cancer Journal Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-023-00930-7/MediaObjects/41408_2023_930_Fig1_HTML.png)
Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models | Blood Cancer Journal
![Percentage of 122 non-HDMTX and 24 HDMTX patients with total CNS-IPI... | Download Scientific Diagram Percentage of 122 non-HDMTX and 24 HDMTX patients with total CNS-IPI... | Download Scientific Diagram](https://www.researchgate.net/publication/337990427/figure/fig2/AS:960057156046848@1605906871000/Percentage-of-122-non-HDMTX-and-24-HDMTX-patients-with-total-CNS-IPI-score-0-to-6-HDMTX.png)
Percentage of 122 non-HDMTX and 24 HDMTX patients with total CNS-IPI... | Download Scientific Diagram
![Central Nervous System International Prognostic Index Impacts Overall Survival in Diffuse Large B-cell Lymphoma Treated with R-Chop in a third Level Cancer Center from Mexico: A Survey of 642 Patients Central Nervous System International Prognostic Index Impacts Overall Survival in Diffuse Large B-cell Lymphoma Treated with R-Chop in a third Level Cancer Center from Mexico: A Survey of 642 Patients](https://www.scielo.org.mx/img/revistas/ric/v73n4//0034-8376-ric-73-4-231-gf1.jpg)
Central Nervous System International Prognostic Index Impacts Overall Survival in Diffuse Large B-cell Lymphoma Treated with R-Chop in a third Level Cancer Center from Mexico: A Survey of 642 Patients
![PDF] Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. | Semantic Scholar PDF] Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/590fd910655ba40d90e40e5a20cdca99feb35b07/3-Table1-1.png)
PDF] Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. | Semantic Scholar
![PDF) Relapsed/Refractory International Prognostic Index (R/ <scp>R‐IPI</scp> ): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma | Henrik Frederiksen - Academia.edu PDF) Relapsed/Refractory International Prognostic Index (R/ <scp>R‐IPI</scp> ): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma | Henrik Frederiksen - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/107234728/mini_magick20231108-1-joni02.png?1699451806)
PDF) Relapsed/Refractory International Prognostic Index (R/ <scp>R‐IPI</scp> ): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma | Henrik Frederiksen - Academia.edu
![Systemic vs. intrathecal central nervous system prophylaxis in primary adrenal/renal diffuse large b-cell Lymphoma: A multi-institution retrospective analysis and systematic review - ScienceDirect Systemic vs. intrathecal central nervous system prophylaxis in primary adrenal/renal diffuse large b-cell Lymphoma: A multi-institution retrospective analysis and systematic review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213048921000303-gr2.jpg)
Systemic vs. intrathecal central nervous system prophylaxis in primary adrenal/renal diffuse large b-cell Lymphoma: A multi-institution retrospective analysis and systematic review - ScienceDirect
![Central Nervous System International Prognostic Index Impacts Overall Survival in Diffuse Large B-cell Lymphoma Treated with R-Chop in a third Level Cancer Center from Mexico: A Survey of 642 Patients Central Nervous System International Prognostic Index Impacts Overall Survival in Diffuse Large B-cell Lymphoma Treated with R-Chop in a third Level Cancer Center from Mexico: A Survey of 642 Patients](https://www.scielo.org.mx/img/revistas/ric/v73n4//0034-8376-ric-73-4-231-gf2.jpg)
Central Nervous System International Prognostic Index Impacts Overall Survival in Diffuse Large B-cell Lymphoma Treated with R-Chop in a third Level Cancer Center from Mexico: A Survey of 642 Patients
![PDF] An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar PDF] An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5835aee9687d11160fd503ad0ecb876e36789aca/3-Table1-1.png)
PDF] An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar
![Application of the Central Nervous System International Prognostic Index ( CNS-IPI) score in daily practice: a retrospective analysis apart from the clinical trial at two centers in Brazil - ScienceDirect Application of the Central Nervous System International Prognostic Index ( CNS-IPI) score in daily practice: a retrospective analysis apart from the clinical trial at two centers in Brazil - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2531137923000445-gr3.jpg)
Application of the Central Nervous System International Prognostic Index ( CNS-IPI) score in daily practice: a retrospective analysis apart from the clinical trial at two centers in Brazil - ScienceDirect
![Cancers | Free Full-Text | First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial Cancers | Free Full-Text | First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial](https://www.mdpi.com/cancers/cancers-12-02192/article_deploy/html/images/cancers-12-02192-g002.png)
Cancers | Free Full-Text | First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial
![Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL - ScienceDirect Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120427454-grabsf1.jpg)
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL - ScienceDirect
![Frontiers | A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups Frontiers | A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups](https://www.frontiersin.org/files/Articles/696147/fonc-11-696147-HTML-r1/image_m/fonc-11-696147-g001.jpg)
Frontiers | A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups
![CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.2015.65.6520/asset/images/large/jco656520ta1.jpeg)
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology
![Full article: Central Nervous System Involvement in Patients with Diffuse Large B Cell Lymphoma: Analysis of the Risk Factors and Prognosis from a Single-Center Retrospective Cohort Study Full article: Central Nervous System Involvement in Patients with Diffuse Large B Cell Lymphoma: Analysis of the Risk Factors and Prognosis from a Single-Center Retrospective Cohort Study](https://www.tandfonline.com/cms/asset/f642200c-d8dc-4144-a2dd-caa6cf2d10cb/dcmr_a_12186821_f0004_c.jpg)